Skip to content

Clinical trials

Completed Phase 3 Multiple Sclerosis, Relapsing-Remitting trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Sclerosis, Relapsing-Remitting Phase: Phase 3 Status: Completed Clear all

55 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20021
20032
20041
20053
20066
20075
20081
20094
20103
20113
20122
20135
20142
20154
20164
20172
20181
20192
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed55

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Biogen17
EMD Serono4
Teva Branded Pharmaceutical Products R&D, Inc.4
Genzyme, a Sanofi Company3
Bayer2
Hoffmann-La Roche2
Novartis2
Anders Svenningsson1
Biocad1
Celgene1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Sclerosis, Relapsing-Remitting55
Multiple Sclerosis27
Recurrence3
Autoimmune Diseases2
Multiple Sclerosis, Chronic Progressive2
Autoimmune Diseases of the Nervous System1
Cognitive Dysfunction1
Demyelinating Autoimmune Diseases, CNS1
Demyelinating Diseases1
Fatigue1

Trials

Showing 1 to 25 of 55. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.